GLYCEMIC AND LIPIDEIC STATUS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

Abstract:

Objective: to know the glycemic and lipidaemic status in patients with acute myocardial infarction, and with the secondary objective to know the effect of age, gender, diabetes, smoking, hypertension on fasting glucose and lipid levels.

Methods and materials: The 74 patients admitted for acute myocardial infarction during the study period of one year were analysed for fasting glucose values and serum levels of total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides.

Results: The mean serum concentrations of total cholesterol, triglycerides, HDL cholesterol and LDL cholesterol were 233.28±45.34, 139.22±41.71, 171.43±36.53 and 27.07±36.53 respectively. Mean levels of total cholesterol, HDL cholesterol, triglycerides and fasting glucose values were not affected by age, gender, BMI, hypertension and smoking. BMI >30kg/m2 was associated with increased levels of total cholesterol(p=0.013) and LDL cholesterol(p=0.014). Also increase LDL cholesterol was seen in male gender(p=0.04). The prevalence of hypercholesterolemia, hypertriglyceridemia and low HDL cholesterol was 82.4%,77% and 78% respectively. Diabetes had no effect on lipid profile.

Conclusion: our study highlighted the prevalence of dyslipidemias associated with myocardial infarction but not significant impact of fasting glucose levels.

Keywords:

fasting glucose - lipidemic status - myocardial infarction - coronary heart disease

Publication History

Article published online:
24 April 2020

• References:

• 1 Leeder SR, Raymond SU, Greenberg H, Lui H, Esson K (2004) A Race Against Time: the Challenge of Cardiovascular Disease in developing economies. New York: The Centre for Global Health and Economic Development, Columbia University. Available:http://www.earth.columbia.edu/news/2004/images/raceagainsttime_FINAL_051104.pdf (accessed online on 10/7/2013)
• 2 Jha P, Gajalakshmi V, Gupta PC, Kumar R, Mony P, et al.(2006) Prospective study of 1 million deaths in India: Rationale, design, and validation results. PLoS Med 3(2): e18
• 3 World Health Statistics 2008. World Health Organisation, www.who.int/en/ (accessed online on 10/7/2013)
• 4 Global Atlas on Cardiovascular Disease Prevention and Control. Mendis S, Puska P, Norrving B editors. World Health Organization (in collaboration with the World Heart Federation and World Stroke Organization), Geneva 2011
• 5 Kannel WB, McGee L. Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study. Diabetes Care MARCH-APRIL 1979;(2): 120-126,
• 6 Wahab N, Cowden E, Pearce N, Gardner M, Merry H, Cox J. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?. J Am Coll Cardiol. 2002;40(10):1748-1754
• 7 Brezinka V, Padmos I. Coronary Heart Disease Risk Factors in Women. Eur Heart J 1994;15:1571-84
• 8 Poultar. N. Global risk of cardiovascular disease. Heart 2003;89(Suppl II):ii2–ii5).
• 9 Gupta R et al. Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5. J Assoc Physicians India. 2012 Mar;60:11-6
• 10 Miller M. Raising an isolated low HDL-C level:Why, how, and when?. CLEVELAND CLINIC JOURNAL OF MEDICINE 2003;70(6):553-560
• 11 Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia. BMJ. 2004 April 3; 328(7443): 807–810
• 12 Murray CJL, Lopez AD, eds. Global burden of disease. Harvard, MA: Harvard School of Public Health, 1996. (Vol 1 of Global Burden of Disease and Injury series.)
• 13 King H, Aubert RE, Herman WH. Global burden of diabetes, 1995- 2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998 Sep;21(9):1414-31.
• 14 Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes Estimates for the year 2000 and projections for 2030. Diabetes Care May 2004 vol. 27 no. 5 1047-1053
• 15 Misra A, Reddy RB, Reddy KS, Mohan A, Bajaj JS. Clustering of impaired glucose tolerance, hyperinsulinemia and dyslipidemia in young north Indian patients with coronary heart disease: a preliminary casecontrol study. Indian Heart J. 1999 May-Jun;51(3):275-80
• 16 Iqbal MP, Shafiq M, Mehboobali N, Iqbal SP, Abbasi K. Variability in Lipid Profile in Patients with Acute Myocardial Infarction from two tertiary care hospitals in Pakistan. J Pak Med Assoc. 2004 Nov;54(11):544-9
• 17 Estari M et al.The investigation of serum lipids and prevalence of Dyslipidemia in urban adults" population of Warangal district, India. Biology and Medicine 2009; 1 (2): 61-65.
• 18 Khader YS et al : Prevalence of Dyslipidemia and its associated factors among Jordan adults. Journal of clinical lipidology 2010; 4:53-58.
• 19 Swaminathan K, Mathanan A, Jebamani S. Diabetes and coronary artery disease in South Asians. The British Journal of Diabetes and Vascular Disease 2013 June. http://dvd.sagepub.com/content/carl/2013/06/10/14746514/3492177
• 20 Enas EA, Senthilkumar A. Coronary Artery Diease in Asian Indians; An update and review. Internet Journal of Cardiology 2001;1(2)
• 21 Singh RB, Bajaj S, Niaz MA, Rastogi SS, Moshiri M. Prevalence of type 2 diabetes mellitus and risk of hypertension and coronary artery disease in rural and urban population with low rates of obesity. Int J Cardiol. 1998 Sep 1;66(1):65-72.
• 22 ASIA PACIFIC COHORT STUDIES COLLABORATION. Blood Glucose and Risk of Cardiovascular Disease in the Asia Pacific Region. Diabetes Care 2004;27:2836–2842
• 23 Ingelsson E, Arnlov J, Sundstrom J, Zethelius J, Vessby B, Lind L. Novel Metabolic Risk Factors for Heart Failure. Journal of American College of Cardiology 2005;46(11):2054-60
• 24 (NCEP) National Cholesterol Education Program. Third report of the National Cholesterol Education Program expert panel on detection, evaluation and treatment of high blood cholesterol in adults (ATP-III) final report. Circulation. 2002;106:3143–421
• 25 Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation. 2002; 106: 3143–3421.
• 26 Kanjilal S, Shanker J, Rao VS, Khadrinarasimhaih NB, Mukherjee M, Iyengar SS, Kakkar VV. Prevalence and component analysis of metabolic syndrome: An Indian atherosclerosis research study perspective. Vasc Health Risk Manag. 2008 February; 4(1): 189–197
• 27 Kamble P, Deshmukh PR, Garg N. Metabolic syndrome in adult population of rural Wardha, central India. Indian J Med Res. 2010 December; 132(6): 701–705
• 28 Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. on behalf of the INTERHEART Investigators. Effect of potentially modifi able risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): casecontrol study. Lancet. 2004;364:937–53
• 29 Joshi et al. Risk Factors for Early Myo cardial Infarction in South Asians Compared With Individuals in Other Countries. JAMA. 2007;297(3):286-294
• 30 Guettier JM, Georgopoulos A, Tsai MY et al. Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population. J Clin Endocrinol Metab 2005; 90: 1705-11
• 31 Grundy SM et al. Primary Prevention of Coronary Heart Disease: Guidance From Framingham : A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction. Circulation. 1998;97:1876-1887